Eosinophilic bronchitis, eosinophilic granuloma, and eosinophilic bronchopneumopathy in 75 dogs (2006-2016). by Johnson, Lynelle R et al.
UC Davis
UC Davis Previously Published Works
Title
Eosinophilic bronchitis, eosinophilic granuloma, and eosinophilic bronchopneumopathy in 
75 dogs (2006-2016).
Permalink
https://escholarship.org/uc/item/80r3n8m9
Journal
Journal of veterinary internal medicine, 33(5)
ISSN
0891-6640
Authors
Johnson, Lynelle R
Johnson, Eric G
Hulsebosch, Sean E
et al.
Publication Date
2019-09-01
DOI
10.1111/jvim.15605
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
S T ANDA RD AR T I C L E
Eosinophilic bronchitis, eosinophilic granuloma,
and eosinophilic bronchopneumopathy in 75 dogs (2006-2016)
Lynelle R. Johnson1 | Eric G. Johnson2 | Sean E. Hulsebosch1 |
Jonathan D. Dear1 | William Vernau3
1Department of Medicine and Epidemiology,
The University of California School of
Veterinary Medicine, Davis, California
2Department of Surgical and Radiological
Sciences, The University of California School
of Veterinary Medicine, Davis, California
3Department of Pathology, Microbiology and
Immunology, The University of California
School of Veterinary Medicine, Davis,
California
Correspondence
Lynelle R. Johnson, 2108 Tupper Hall, UC
Davis School of Veterinary Medicine, Davis,
CA 95616.
Email: lrjohnson@ucdavis.edu
Abstract
Background: Eosinophilic lung disease is a poorly understood inflammatory airway
disease that results in substantial morbidity.
Objective: To describe clinical findings in dogs with eosinophilic lung disease defined
on the basis of radiographic, bronchoscopic, and bronchoalveolar lavage fluid (BAL)
analysis. Categories included eosinophilic bronchitis (EB), eosinophilic granuloma
(EG), and eosinophilic bronchopneumopathy (EBP).
Animals: Seventy-five client owned dogs.
Methods: Medical records were retrospectively reviewed for dogs with idiopathic
BAL fluid eosinophilia. Information abstracted included duration and nature of clinical
signs, bronchoscopic findings, and laboratory data. Thoracic radiographs were evalu-
ated for the pattern of infiltrate, bronchiectasis, and lymphadenomegaly.
Results: Thoracic radiographs were normal or demonstrated a bronchial pattern in
31 dogs assigned a diagnosis of EB. Nine dogs had intraluminal mass lesions and were
bronchoscopically diagnosed with EG. The remaining 35 dogs were categorized as
having EBP based on radiographic changes, yellow green mucus in the airways,
mucosal changes, and airway collapse. Age and duration of cough did not differ
among groups. Dogs with EB were less likely to have bronchiectasis or peripheral
eosinophilia, had lower total nucleated cell count in BAL fluid, and lower percentage
of eosinophils in BAL fluid compared to dogs in the other 2 groups. In contrast to
previous reports, prolonged survival (>55 months) was documented in dogs with EG.
Conclusions and Clinical Importance: Dogs with eosinophilic lung disease can be
categorized based on imaging, bronchoscopic and BAL fluid cytologic findings.
Further studies are needed to establish response to treatment in these groups.
K E YWORD S
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cell count.
Received: 31 March 2019 Accepted: 15 August 2019
DOI: 10.1111/jvim.15605
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any
medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
© 2019 The Authors. Journal of Veterinary Internal Medicine published by Wiley Periodicals, Inc. on behalf of the American College of Veterinary Internal Medicine.
J Vet Intern Med. 2019;33:2217–2226. wileyonlinelibrary.com/journal/jvim 2217
1 | INTRODUCTION
Pulmonary eosinophilia can develop in response to parasitic, fungal, or
neoplastic diseases or as an immunologic response to an unknown trig-
ger. Dogs with idiopathic pulmonary eosinophilia have a spectrum of
clinical presentations and bronchoscopic appearances,1 but little is
known about the clinical features of these various manifestations of
disease. Mild changes in the airways of some dogs were interpreted to
represent a form of bronchitis.1 Some dogs have severe radiographic
abnormalities and bronchoscopic changes including a polypoid appear-
ance to the airways, visible bronchiectasis, yellow green mucus coating
multiple airways, and airway collapse. This pattern was described as
eosinophilic bronchopneumopathy (EBP), a systemic and parenchymal
disease process causing cough and nasal discharge in young- to middle-
aged dogs.2
Several reports have defined a variant of eosinophilic disease char-
acterized by granulomatous masses.3-6 Diagnostic imaging findings in
these cases often resemble a neoplastic process.5,7 Once, this disorder
was considered the most common form of eosinophilic lung disease1
and diagnosis was associated with a guarded prognosis for recovery.
Clinical experience has demonstrated that intraluminal airway lesions
in eosinophilic granuloma (EG) often appear similar to the fungal gran-
ulomas visualized in sinonasal aspergillosis. Aspergillus organisms were
isolated from culture of bronchoalveolar lavage fluid (BAL) in 2 of
22 dogs with EBP,2 but no studies to date have identified a fungal ori-
gin for this disease or for EG.
Eosinophilic lung disease in dogs previously has been described as
a heterogenous group of disorders similar to the description used in
humans, with disease primarily in the airways or parenchyma, or in
both segments of the lung,8,9 but large-scale descriptive studies are
lacking. The aim of our retrospective study was to define clinical find-
ings in dogs that could be categorized as eosinophilic bronchitis (EB),
EBP, and EG. We hypothesized that cases would be similar in demo-
graphics but that dogs with EB would have shorter duration of clinical
signs, less severe peripheral eosinophilia and basophilia, and less mar-
ked evidence of inflammation in BAL fluid. We also hypothesized that
dogs with EG would more often display radiographic evidence of
bronchiectasis, because of severe inflammation or as a predisposing
factor for mucus inspissation and plugging.
2 | MATERIALS AND METHODS
Medical records at the William R. Pritchard Veterinary Medical Teach-
ing Hospital at the University of California-Davis were searched for all
dogs having bronchoscopy performed between January 1, 2006, and
January 1, 2016. Bronchoscopy records were evaluated for cases with
BAL fluid eosinophilia. At least 1 lobar lavage cytology had to contain
>14% eosinophils, which represented the 90th percentile for this cell
type determined in a BAL study of dogs with histologically normal
lungs.10 In addition, cases with a clinical diagnosis of eosinophilic lung
disease (recorded as EBP, EB, pulmonary infiltrates with eosinophilia, or
EG) were identified from the clinical diagnosis field or pathology results
in the medical record. Inclusion criteria were documentation of respira-
tory signs (eg, cough, nasal discharge, difficulty breathing, or tachypnea)
in conjunction with eosinophilic lower respiratory tract cytology or his-
topathology. Cases were excluded if pulmonary eosinophilia could be
ascribed to cardiac or pulmonary parasitism, foreign body disease, or a
paraneoplastic process, based on clinical data obtained.
Dogs were placed under general anesthesia using a protocol deemed
most appropriate by the anesthesia service and were positioned in sternal
recumbency. Computed tomography (CT), when performed, was com-
pleted immediately before bronchoscopy, and results were abstracted
from the imaging report. When an endotracheal tube size >#7 could be
placed, bronchoscopy was performed through a bronchoscopic adaptor
attached to the endotracheal tube. A 4.9-mm outer diameter flexible
videoendoscope (Olympus P180 or GIF-XP180N, Center Valley, Pennsyl-
vania) was utilized, and isoflurane was used to provide general anesthesia.
Smaller dogs were maintained at a stable plane of anesthesia with a con-
stant rate IV infusion of propofol at 6 μg/kg/min; oxygenation was
maintained by the use of jet ventilation via a 14-gauge angiocatheter at a
rate of 180 breaths per minute, and a 3.8-mm outer diameter flexible
videoendoscope was used (Olympus BIF 3C160). Bronchoscopy was per-
formed by 1 of the authors (L.R.J., S.E.H., J.D.D.) or a house officer trained
by the authors. Pulse oximetry was monitored throughout the procedure,
and the procedure was interrupted if hemoglobin saturation with oxygen
decreased below 85%.
The endoscopist was aware of prior diagnostic imaging results at
the time of the procedure. All dogs were evaluated in standardized
fashion, with interrogation of all accessible lobar bronchi in the follow-
ing order: left cranial (cranial and caudal segments), left caudal, right
cranial, right middle, accessory, and right caudal lung lobes. Bronchos-
copy findings of moderate to severe airway hyperemia, mucus exuda-
tion, airway collapse, and presence of intraluminal material were
recorded using a combination of drop-down menus and free field text
boxes within the endoscopy report.
After complete visual inspection of the airways, the bronchoscope
was withdrawn from the airways to irrigate the channel with sterile
saline and wipe debris from the outer surface, then reinserted to com-
plete BAL at specific site or sites chosen by the endoscopist based on
abnormalities found on radiographs or bronchoscopy. When no specific
abnormalities were identified, the right middle lobe and the caudal por-
tion of the left cranial lung lobe were sampled most commonly. Lavage
was performed at ≥1 sites by wedging of the endoscope in the smallest
possible airway followed by instillation and aspiration of warm, sterile
saline through the biopsy channel of the endoscope. Lavage volume
was based on the size of the dog, the outer diameter of the broncho-
scope used, and the ability to wedge the bronchoscope in the airway in
a manner that provided adequate return. An approximate guideline of
1 mL/kg/lavage site was utilized, and fluid retrieval was considered
acceptable if visible foam was present in the syringe suggesting the
presence of surfactant or if lavage fluid was obviously flocculent or con-
tained mucoid material. One to 4 lavages were performed as clinically
indicated, and the volume recovered was recorded for each separate
lavage. When indicated, endobronchial biopsy samples or samples from
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intraluminal mass lesions were collected and placed in 10% neutral buff-
ered formalin for histopathologic evaluation.
Bronchoalveolar lavage fluid was processed within 1 hour of collec-
tion. Lavages from distinct lobar sites were submitted separately for
cytologic analysis by board-certified clinical pathologists. Total nucle-
ated cell counts (TNCC) were performed on unfiltered BAL fluid using
an automated cell counter (Advia 120; Siemens, Deerfield, Illinois) and
reported as TNCC/μL. Slides were prepared for cytologic analysis by
cytocentrifugation (Cytospin3; ThermoShandon, Pittsburgh Pennsylva-
nia) followed by Wright-Giemsa staining using an automated cell stainer
(Model 7151 Wescor Aerospray Hematology Pro; ELITech Bio-Medical
Systems, Logan, Utah). A differential cell count was based on an assess-
ment of 200 cells. Normal reference values used for canine BAL fluid
differential cell counts in our laboratory are approximately 80% macro-
phages, 7% lymphocytes, 5% neutrophils, 6% eosinophils, 1% mast cells,
and 1% epithelial cells in dogs.10 The number of lavages per dog with
BAL eosinophilia, highest TNCC/μL, and the highest eosinophil percent-
age for each dog were recorded. Septic suppurative inflammation was
documented by identification of bacterial phagocytosis by neutrophils
and was used to identify infectious lower respiratory disease.
A pooled sample of BAL fluid was plated onto 5% sheep blood agar
and MacConkey's agar for isolation of aerobic organisms and
pleuropneumonia-like organism base with thallium acetate (antifungal)
and penicillin G (antibacterial) additions for isolation ofMycoplasma spp.
At the discretion of the attending clinician, samples were plated onto
pre-reduced anaerobic Brucella plates (Anaerobe Systems, Morgan Hill,
California) for anaerobic culture or inhibitory mold agar (Hardy Diagnos-
tics, Santa Maria, California) for fungal culture. Bacterial growth was
assessed in a semi-quantitative fashion and was reported as 1+, 2+, 3+,
or 4+ based on the number of quadrants containing bacterial growth.
Standard biochemical methods were used to identify cultured bacteria
before September 2013 and afterward by matrix-assisted laser des-
orption/ionization time-of-flight (Bruker Daltonics Microflex LT, Biller-
ica, Massachusetts). Dogs with >2+ growth of potential pathogens on
aerobic, anaerobic,Mycoplasma, or fungal culture with or without septic
cytology were diagnosed with lower respiratory tract infection.
Underlying or coincident disease processes associated with airway
eosinophilia were investigated by ancillary tests, including airway BAL
fluid cultures, fecal parasite evaluations, serologic heartworm testing,
or histopathology, at the discretion of the attending clinician.
History and physical examination findings were retrieved from
medical records included in the electronic database of the hospital and
were reviewed by 1 of the authors (L.R.J.). Data abstracted from the
medical record included age, breed, sex, type, and duration of clinical
signs, medication administered within the previous week, and results
of a CBC. Complete blood counts were evaluated for total white blood
cell count, count above or below the reference range for our labora-
tory (6000-13 000/μL) and for total eosinophil and basophil counts, as
well as those above the normal range (eosinophils >1500/μL and
basophils >50/μL). Radiographs typically were performed the day
before bronchoscopy and ≤1 week before the procedure. All radio-
graphs were retrospectively reviewed by a board-certified radiologist
(E.G.J.) who was aware of pulmonary eosinophilia. Radiographs were
interpreted as either normal or as having interstitial, nodular, bron-
chial, or alveolar patterns, with many dogs having >1 type of radio-
graphic pattern. The presence of bronchiectasis, bronchial plugging
(characterized by elongated tubular or cylindrical soft tissue infiltrates
filling bronchi), and lymphadenomegaly was recorded.
Dogs were divided into 3 groups for statistical comparison. Dogs
with normal thoracic radiographs or primarily a bronchial pattern in
conjunction with bronchoscopic findings of minimal mucosal irregular-
ities, hyperemia alone, mild or focal mucus, and lack of airway collapse
were categorized as having EB (Figure 1). Dogs with bronchoscopic
evidence of intraluminal eosinophilic mass lesions plugging ≥1 airways
were described as having EG (Figure 2). Given the historically guarded
prognosis of dogs with EG, records of affected dogs also were evalu-
ated for information describing treatment response and survival. Dogs
with bronchoscopic findings of thick mucoid exudate, mucus plugging,
polypoid proliferations of the mucosa of the airways, bronchiectasis,
airway collapse, lack of granuloma formation, and diagnostic imaging
abnormalities including bronchial, interstitial, nodular, or alveolar pat-
terns were diagnosed with EBP (Figure 3).
2.1 | Statistical analysis
Data were assessed for normality using the D'Agostino and Pearson
omnibus normality test (GraphPad Prism version 5.0f, San Diego,
California). Normally distributed data are presented as mean ± standard
deviation, and data with a non-Gaussian distribution are presented as
median with range. Results for nonparametric data were compared
among groups using the Kruskal-Wallis test with post hoc Dunn's multiple
F IGURE 1 Bronchoscopic image from a dog with eosinophilic
bronchitis reveals airway hyperemia. Airway openings are normal in
shape and size, the epithelial lining is smooth, minimal mucus is
present, and no airway collapse is noted
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comparison test. Chi-square analysis or Fisher's exact test was used to
compare the number of dogs among groups with leukocytosis, peripheral
eosinophilia, bronchiectasis, and other radiographic infiltrates.
3 | RESULTS
Between January 1, 2006, and January 1, 2016, 569 dogs had bron-
choscopy performed. Bronchoalveolar lavage eosinophilia >14% in at
least 1 lobar lavage was documented in 85 dogs. Ten dogs were
excluded from further analysis, including 6 dogs with foreign body
migration or broncho-pneumonia, 2 dogs with pulmonary carcinoma,
and 2 dogs with disease related to Dirofilaria immitis or Oslerus osleri
infections. In the remaining 75 dogs, heartworm antigen test (Dirocheck
Heartworm Antigen test kit; Zoetis, Parsippany, New Jersey) was nega-
tive, and fecal examinations, including flotation, sedimentation, and
Baermann examination were negative in 24 of 24 dogs. Coccidioidomy-
cosis serology was negative in 13 of 13 dogs tested.
Overall, the group of 75 affected dogs ranged in age from
0.6-15 years at the time of diagnosis (median, 6 years) and was
comprised of 4 Labrador Retrievers and 4 Standard Poodles, 3 each
of Cocker Spaniel, German Shepherd, and Pomeranian, and 2 each
of Rottweiler, Australian Shepherd, Jack Russell Terrier, and Shih
Tzu. The remaining dogs were breeds represented once or were
mixed breed dogs. There were 3 intact female, 35 female spayed,
3 intact male, and 34 male neutered dogs. The most common clini-
cal complaint was cough (69/75; 92%), with a median duration
before presentation of 6 months (range, 1.5 days to 96 months).
Nasal discharge was recorded in 21 of 75 dogs (28%) with duration
ranging from 0.2 to 36 months (median, 5 months). Three dogs (4%)
were presented for tachypnea and 3 dogs (4%) were presented for
abnormal respiratory sounds described by owners as gurgling,
snorting, or wheezing. Medications administered in the week before
diagnostic testing included corticosteroids in 5 dogs and antimicro-
bials in 21 dogs.
F IGURE 2 Bronchoscopic (A) and
CT image (B) from a dog with
eosinophilic granuloma. In (A), a large
yellow mass lesion is partially
obstructing a bronchus. The CT in
(B) demonstrates generalized and
severe saccular dilation of bronchi
with thickening of airway walls and a
large amount of soft tissue
attenuating material obstructing the
bronchial lumen at multiple locations.
Left lateral (C) and dorsoventral
radiographs (D) show a severe
bronchial pattern with bronchiectasis
and, in particular, gross enlargement
of the right cranial and right caudal
lobar bronchi that are filled with soft
tissue opacity and are tubular in
shape
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A diagnosis of EB was made in 31 of 75 dogs (41%, Table 1).
Radiographs were available for review in 28 of 31 EB dogs and were
reported as normal in 17 of 28 (61%) dogs, and a bronchial pattern
was described in 11 of 28 (39%) dogs. Bronchoscopy was reported as
normal in 6 of 31 dogs, airway hyperemia was present in 25 of
31 dogs, and mild deposits of mucus were noted in 7 of 31 dogs.
Bronchoalveolar lavage eosinophilia was present in only 1 of multiple
lung lavages in 19 of 31 (61%) dogs. In 10 dogs, BAL fluid eosinophilia
was noted in 2 of 2 lavages. One dog each had BAL fluid eosinophilia
in 2 of 3 or 3 of 3 lavage sites. One dog with concurrent laryngeal dys-
function had bacterial sepsis and growth of E. coli and Streptococcus
on culture. A second dog had a single colony of Aspergillus detected
on the aerobic bacterial culture, which was considered a contaminant.
Dogs with EB included 4 Labrador Retrievers and 2 each of Jack Rus-
sell Terrier and Australian Shepherd. The group comprised 15 female
(1 intact) and 16 male (1 intact) dogs. Median weight was 23.6 kg with
7 dogs <10 kg, 3 dogs 10-20 kg, and 20 dogs >20 kg.
Bronchoscopy identified intraluminal EG in 9 of 75 dogs (12%).
Airway hyperemia was present in 5 of 9 dogs and mucus exudation
and inspissation in 9 of 9 dogs. Thoracic radiographs were abnormal
in all dogs, with a bronchial pattern (9/9), bronchiectasis (6/9), bron-
chial plugging with intraluminal soft tissue opacities (5/9), nodular or
mass lesions (5/9), alveolar or interstitial infiltrates (4/9), and hilar lym-
phadenomegaly (1/9). In 1 dog, BAL fluid eosinophilia was found in
only 1 of 3 lavages, and in a second dog, BAL fluid cytology identified
neutrophilic inflammation, but EG was reported on histopathologic
examination of intraluminal mass lesions. In the remaining 7 dogs, BAL
fluid eosinophilia was found in 1/1 lavage, 2/2 lavages, 2/3 lavages,
3/3 lavages (3 dogs) and 4/4 lavages. One dog had septic suppurative
inflammation with isolation of Pasteurella canis considered a second-
ary infection. Fungal culture was negative in 3 of 3 dogs tested, and
histopathology of the intraluminal granulomas failed to identify infec-
tious organisms in 2 of 2 dogs evaluated. In dogs with EG, mixed
breed dogs were most common (4/9) and no dog breed was represen-
ted more than once. There were 4 female spayed, 2 male, and 3 male
neutered dogs. Median weight was 21.4 kg with 3 dogs <10 kg and
the remainder above 19 kg.
The remaining 35 dogs (47%) were considered to have EBP based
on multiple radiographic and bronchoscopic findings. A bronchial pat-
tern was the most common radiographic abnormality (29/35; 83%)
followed by bronchiectasis (21/35; 60%). Hilar lymphadenomegaly
was found in 3 of 35 (9%) dogs. Bronchoalveolar lavage fluid analysis
identified septic suppurative inflammation in 1 dog with isolation of
Pasteurella spp., and BAL fluid fungal culture was negative in 4 of
4 dogs tested. Eosinophilia in BAL fluid cytology was found in 1/1
lavages in 3 of 35 dogs, 2/2 lavages in 23 of 35 dogs, 2/3 lavages in
2 of 35 dogs, and 3/3 lavages in 7 of 35 dogs. In this group, 3 were
Standard Poodles, and there were 2 each of Cocker Spaniels, Pomera-
nians, and Shih Tzus. There were 2 intact female dogs, 16 female
spayed, and 17 male neutered dogs. Median weight was 21.2 kg with
13 dogs <10 kg, 4 dogs 10-20 kg, and 18 dogs >20 kg.
Overall, in 72 dogs with BAL fluid eosinophilia that had radio-
graphs available for review, a bronchial pattern was the most common
radiographic finding followed by bronchiectasis (Table 1). Dogs with
EB had radiographic evidence of bronchiectasis detected significantly
less often than dogs did with EG or EBP (P = .002), and a nodular infil-
trate was significantly more common in EG than in other diseases
(P = .005). Computed tomography was performed in 3 of 31 dogs with
EB, 5 of 9 dogs with EG, and 4 of 35 dogs with EBP. Findings are not
specifically addressed here given the small number of cases that had
CT performed, and the availability of previous descriptions of CT find-
ings in dogs with pulmonary eosinophilia.5,7
F IGURE 3 Bronchoscopic images from two different dogs with
eosinophilic bronchopneumopathy reveal yellow green mucus
obscuring an airway (A) and airway collapse with nodular epithelial
changes (B)
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Median duration of cough did not differ among groups (P = .27,
Table 2). Dogs with EBP were significantly more likely to have periph-
eral leukocytosis than were dogs with EB or EG (P = .03), and peripheral
eosinophilia was present in significantly fewer dogs with EB than in
dogs with EBP or EG (P < .0001, Figure 4). There were no differences in
other white blood cells including basophils among groups. Total nucle-
ated cell counts in BAL fluid of dogs with EB were significantly lower
(median, 980; range, 300-4240) than those in dogs with EBP (median,
3360; range, 550-33 800) or EG (median, 2630, range, 1920-16 940,
P < .0001), and percentages of BAL eosinophils were significantly lower
in dogs with EB than in dogs with EBP and EG (P < .0001, Figure 5).
Follow-up information was obtained from the medical records of
9 dogs with EG. Although treatment was not standardized prospec-
tively, all dogs were started on prednisone at approximately 1 mg/kg
PO q12h. Nebulization with saline was initiated in 6 of 9 dogs and
N-acetylcysteine was administered PO to 5 of 9 dogs. One dog under-
went lobectomy of the left caudal lobe and then the left cranial lung
lobe and has been maintained on inhaled corticosteroids and cyclospor-
ine PO for >55 months at the time of writing. One dog was known to
have died 4 months after the diagnosis, and 1 dog was tapered off
corticosteroids 39 months after diagnosis when bacterial of developed.
The remaining 6 dogs were reportedly doing well on corticosteroids
2 weeks to 15 months (median, 8 months) after the diagnosis of EG
before being lost to follow-up.
4 | DISCUSSION
To our knowledge, this study is the first to report features highlighting
the diversity of eosinophilic lung disease in a large group of dogs and
TABLE 1 Radiographic findings in 72
of 75 dogs with BAL fluid eosinophilia
that had radiographs available for review
EB (n = 28) EG (n = 9) EBP (n = 35) Total (%) P value
Normal radiographs 17 0 0 17/73 (23) NA
Bronchial pattern 11 9 32 52/73 (71) NA
Interstitial infiltrates 0 6 0 6/73 (8) ND
Alveolar infiltrates 0 4 7 11/73 (15) .20
Bronchial plugging 0 5 12 17/73 (23) .27
Nodular pattern 0 5a 3 8/73 (11) .005
Bronchiectasis 6a 7 21 35/73 (48) .007
Lymphadenopathy 0 1 3 4/73 (5) ND
Individual dogs had more than one radiographic pattern.
Abbreviations: EB, eosinophilic bronchitis; EBP, eosinophilic bronchopneumopathy; EG, eosinophilic
granuloma; NA, test not applicable due to inclusion criteria; ND, test not performed due to low numbers.
aSignificantly different than other entries within the row.
TABLE 2 Demographic and clinicopathologic findings in dogs with BAL fluid eosinophilia
EB (n = 31) EG (n = 9) EBP (n = 35) P-value
Age (y) 8.5 (0.6-15) 6 (4-10) 4.0 (1-13) .08
Weight (kg) 23.6 (5.4-41.8) 21.4 (5.9-44.6) 20.5 (2.1-40) .28
Nasal discharge 11/31 3/9 7/35 .27
Cough 27/33 9/9 33/35 .41
Duration of cough (mo) 7 (0.5-60) 2 (0.5-60) 6 (0.07-96) .31
WBC/μL 11 920 (7760-21 287) 12 900 (10 190-29 150) 14 190 (6860-32 390) .21
Number of dogs with leukocytosis (>13 000) 8/28 3/9 21/35a .03
Peripheral eosinophils/μL 676 (25-2064)a 2202 (621-15 450) 1651 (185-17 003) <.0001
Number of dogs with peripheral eosinophilia >1500 2/28a 6/9 18/35 <.0001
Peripheral basophils/μL 30 (0-246) 22 (0-1458) 26 (0-2520) .93
Number of dogs with peripheral basophilia >50 6/28 3/9 14/35 .25
BAL TNCC/μL 980 (300-4240)a 2630 (1920-16 940) 3360 (550-33 800) <.0001
%BAL eosinophils 21 (15-64)a 55 (24-91) 61 (23-95) <.0001
Values represent medians (range).
Abbreviations: EB, eosinophilic bronchitis; EBP, eosinophilic bronchopneumopathy; EG, eosinophilic granuloma; TNCC, total nucleated cell count; WBC,
white blood cell count.
aSignificantly different than other entries within the row.
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to describe the prevalence of intraluminal EG as part of this syndrome.
Dogs with minimal to no radiographic and minimal bronchoscopic
changes were categorized as having EB. These dogs less commonly
had peripheral eosinophilia, had lower TNCC in BAL fluid, and had
lower percentages of eosinophils in BAL fluid. The most common cat-
egory comprised dogs diagnosed with EBP based on radiographic infil-
trates and bronchoscopic abnormalities, whereas the least common
category consisted of dogs with eosinophilic material filling the air-
ways (ie, EG).
Our study identified multiple clear differences among the 3 disease
syndromes, with the most easily identified being the presence of large
intra-airway mass lesions in EG. It is unclear whether the syndrome
characterized here is the same as that described as eosinophilic
pulmonary granulomatosis in the veterinary literature. Two reports of
that condition describe parenchymal lesions infiltrated by epithelioid
cells, macrophages, and eosinophils surrounded by fibroplasia that
destroy the local pulmonary architecture.6,11 In those reports, the
alveolar architecture surrounding the granulomas remained intact and
was histologically characterized by type II pneumocyte proliferation
with eosinophilic infiltration. Some cases11 were characterized by
eosinophilic infiltration of other organs, resembling hypereosinophilic
syndrome.12 In contrast, the disease in dogs with EG described here
generally was confined to intra-airway accumulation of mass-like
material, more similar to what was described in a CT study of dogs
with eosinophilic granulomatosis.5 Given that some previous reports
did not employ bronchoscopy,6,11 it is possible that only pulmonary
F IGURE 4 Total WBC did not differ among groups (A) although the percentage of dogs with EBP that had peripheral leukocytosis was
significantly higher than in the other 2 groups. Peripheral blood eosinophils (B) were significantly lower in dogs with EB in comparison to dogs
with EG and EBP. Dashed lines represent reference intervals
F IGURE 5 Total nucleated cell counts in BAL fluid were significantly lower in dogs with EB compared to those with EG and EBP (A; dashed
line represents the normal value), and percentage BAL fluid eosinophilia was also lower in that group (B). Only dogs with BAL fluid eosinophil
percentage exceeding 14% were evaluated here
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parenchymal involvement was reported for those cases because the
possibility of intra-airway disease was not investigated.
A second clear difference among the 3 types of eosinophilic lung
disease categorized in our study was the difference in peripheral leu-
kocyte variables and pulmonary eosinophilic responses. Leukocytosis
was present in 44% of all dogs with BAL fluid eosinophilia reported
here, with a significantly higher number of dogs with EBP demonstrat-
ing leukocytosis (60%) in comparison to dogs with EB or EG, although
neutrophils, lymphocytes, monocytes, and basophils did not differ
among groups. Dogs with EB had lower numbers of peripheral eosino-
phils and more typically had a peripheral eosinophil number within the
reference range compared to dogs with EG or EBP, suggesting more
severe pulmonary involvement in the latter 2 conditions.
In addition, dogs with EB had lower percentages of eosinophils in
BAL fluid compared to the other 2 disease syndromes. These findings
provide an interesting contrast to an earlier description of EBP.2 In
that study, the severity of eosinophilic lung disease was categorized
based on BAL eosinophil percentages of 0%-20% (mild), 20%-50%
(moderate), and >50% (severe). Had that methodology been employed
here, slightly <50% of dogs with EB would fit in the mild category of
EBP, but all remaining dogs in that group and most dogs in the other
2 groups would fit into the moderate to severe category of inflamma-
tion. Therefore, the method of severity scoring based on BAL eosino-
phil percentages appears to be less discriminating than our proposed
categorization, which takes into account multiple clinical features. A
stricter definition of pulmonary eosinophilia might be obtained by
requiring increased eosinophil percentages in >1 lavage fluid, particu-
larly given the knowledge that cytologic inflammatory responses can
differ among lobes in 37% of dogs with pulmonary disease.13 None-
theless, in our study, dogs with EG and EBP had higher TNCC in BAL
fluid as well as higher percentages of BAL fluid eosinophils, which
indicates more marked airway inflammation.
A final indicator of increased severity of disease in EG and EBP
was the increased radiographic detection of bronchiectasis in these
conditions in comparison to EB. Bronchiectasis has been a consistent
finding in dogs with eosinophilic lung disease and EG.5,7,14 This obser-
vation is likely not a consequence of longer duration of disease,
because there was no significant difference in duration of cough
among the 3 disease groups and there was no difference in the age of
affected dogs. Instead, bronchiectasis is likely a consequence of the
tissue damaging effects of eosinophils on the support structures of
the airways, given that dogs with EG and EBP had both higher BAL
fluid TNCC and percentage eosinophils.
In humans, eosinophilic lung disease has many different forms that
often are divided into disorders that affect the airways, those that
involve the alveolar space, and those that are part of a systemic
response.9 Variants of airway disease include asthma and allergic bron-
chopulmonary aspergillosis (ABPA), a form of asthma characterized by
hypersensitivity to Aspergillus. Eosinophilic granulomatosis with vasculi-
tis (previously referred to as Churg-Strauss syndrome) is a very rare dis-
order characterized by nodules surrounding blood vessels that can be
found in association with severe asthma,15,16 and it does not resemble
the EG described here. The only syndrome in humans with a
presentation somewhat similar to that of EG in dogs described here
is aspergilloma, a noninvasive intra-airway fungal infection treated with
itraconazole or surgical excision.17,18 It is often found in association with
bronchiectasis and also can be found with ABPA.19,20 However, in our
study, all dogs with EG tested for fungal infection were negative on cul-
ture or histopathology, indicating a lack of similarity to this condition in
humans.
Although our study was not designed to assess treatment response
in EG, given the time frame in which the dogs were examined, some
follow-up information was available for all 9 dogs. Dogs were all treated
similarly with high doses of glucocorticoids PO, and most were treated
with medication (eg, N-acetylcysteine PO) or airway treatment such as
saline nebulization designed to improve mobilization of secretions.
Despite the reported poor prognosis for this disease, virtually all dogs
showed improvement or resolution of clinical signs, with documented
survival >39 and 55 months in 2 dogs. Further prospective studies of
eosinophilic lung disease are needed to determine optimal treatment.
The original report of EBP identified a predilection for the disease in
Siberian Huskies and Alaskan Malamutes,2 but only 1 Malamute and
1 Husky were included in our study. Interestingly, sled dogs trained in
cold weather have been reported to develop airway eosinophilia,21
which could reflect a breed predilection or shared environmental trigger
leading to this type of response to injury. Multiple breeds were affected
by the 3 forms of eosinophilic disease described in our study, and the
disease was more common in large breed dogs, as >50% of dogs exam-
ined here weighed >20 kg. Only 5 dogs weighed <5 kg, all of which
were diagnosed with EBP rather than EB or EG.
Eosinophilic lung disease has been associated with increased tis-
sue destruction and remodeling, collagenolytic activity and collagen
turnover, and damage to epithelial attachment to the basement mem-
brane, as indicated by increased procollagen type III aminoterminal
peptide, matrix metalloproteinases, and laminin-5 gamma 2-chain in
BAL fluid.22-25 However, some of these findings also have been
reported in BAL fluid of healthy dogs or dogs with other lung diseases.
The type of eosinophilic lung disease examined in those studies is not
clear, and it appears that dogs we would characterize as EB were com-
bined with those we would define as EBP.22-24 Future studies with
more strict definitions of the subsets of eosinophilic lung disease
could provide better understanding of the molecular mechanisms and
underlying immunopathogenesis of disease.
The retrospective nature of our study limited standardized col-
lection of results, particularly information on recall of primary pre-
senting complaints, duration of signs, and previous administration of
medications. Multiple bronchoscopists performed the procedures
over this 10-year time frame, and videotapes were unavailable for
review that could have been used to clarify the severity of lesions
and to identify bronchiectasis. However, 3 of the authors (L.R.J.,
S.E.H., J.D.D.) performed or attended over 67% of the procedures,
and all endoscopists were similarly trained in identification of lesions
and completion of reports, lending some reliability to the methodol-
ogy. Interestingly, bronchiectasis could be identified radiographically
in a number of dogs, including those with EB. We did not include a
severity score for bronchiectasis or for interpretation of other
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radiographic lesions and believe that CT data would be better uti-
lized for that assessment in a prospective study. Finally, pulmonary
parasitism is very uncommon in our area of the country (western
USA), which resulted in few dogs having fecal evaluations per-
formed. Therefore, it is possible that some of the cases that we
classified as having idiopathic BAL eosinophilia actually had parasitic
lung disease, but we believe this to be unlikely.
In conclusion, dogs with eosinophilic lung disease have different
manifestations of disease and can be assigned to 1 of 3 categories
based on hematologic, imaging, and bronchoscopic findings in con-
junction with BAL fluid cytologic assessment. It is unclear whether
these various forms of pulmonary eosinophilia share the same
etiopathogenesis or represent distinct disease processes. If they are var-
iants of a single disease, then they might represent a continuum of the
disease spectrum. Alternately, variations could result from different host
or environmental influences in the dogs affected. Determining the
specific type of eosinophilic lung disease and its immunopathogenesis
could provide improved treatment modalities and more predictable
response to treatment. Eosinophilic granuloma often has been given a
guarded prognosis, although disease remission has been reported,4 and
acceptable response to treatment was noted in several dogs in our
study. Response to PO glucocorticoid treatment has been associated
with normalization of parameters of immune function in dogs with
EBP,2 but prolonged treatment is often required because relapses are
common. The use of inhalation treatment in dogs with EBP has been
suggested to result in only partial response,26 but it is possible that the
less severe form of EB might prove highly responsive to topical
treatment.
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